Renal Disease Clinical Trials in Beijing, Beijing Municipality
6 recruitingBeijing, Beijing Municipality, China
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
End Stage Renal Disease on DialysisHyperphosphatemiaChronic Kidney Disease Requiring Chronic Dialysis
R1 Therapeutics168 enrolled26 locationsNCT06712654
Recruiting
Phase 3
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
HyperphosphatemiaDialysisChronic Kidney Disease, Receiving Dialysis+1 more
Alebund Pharmaceuticals264 enrolled42 locationsNCT06933472
Recruiting
Phase 1Phase 2
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
End-Stage Renal Disease Requiring Haemodialysis
Suzhou Alphamab Co., Ltd.12 enrolled1 locationNCT07201467
Recruiting
Not Applicable
Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)
End Stage Renal Disease on Dialysis
Peking University People's Hospital34 enrolled1 locationNCT07111260
Recruiting
Phase 4
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
End Stage Renal Disease (ESRD)
Chengdu Qingshan Likang Pharmaceutical Co., Ltd400 enrolled21 locationsNCT06597201
Recruiting
Comparative Study of Prognosis and QOL Between APD-RPM and CAPD
End Stage Renal Disease
Chinese PLA General Hospital750 enrolled1 locationNCT05738525